Maruyama A

ORCID: 0009-0007-8700-8679 · 1 paper in corpus
2025
Advances in therapy ·doi:10.1007/s12325-025-03123-9

IntroductionTreatment interruptions due to adverse drug reactions (ADRs) are common in iron deficiency anemia (IDA). We evaluated medication completion rates and quality of life (QoL) changes in patients with IDA after starting ferric citra…